Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Masimo Corporation - Common Stock (NQ: MASI )

162.63 +4.70 (+2.98%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Masimo Announces the First FDA-cleared “Over-the-Counter” Fingertip Pulse Oximeter
From Masimo
Via Business Wire
New Peer-Reviewed Study Finds That Masimo SET® Pulse Oximetry Measures Accurately on Both Black and White People Even During Low Perfusion
From Masimo
Via Business Wire
Apple's Win
We've also got some productivity tips for the new year. 
Via The Motley Fool
Tim Cook Opens Up On Apple Watch Ban, Licensing Masimo' Tech: 'We're Focused On Appeal'
Apple CEO Tim Cook has confirmed the company's plan to appeal the ban on its Apple Watch imposed in a patent dispute with Masimo, stating they have no intention of settling and will focus on the... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
What Wall Street Experts Are Saying About Apple Ahead Of Earnings
Bulls and bears divided on Apple ahead of 'likely not great' report. 
Via Talk Markets
Vision Pro Exceeds Expectations, Banned Apple Watch Feature Saves Teen And More: Top News In Appleverse This Week
From booking a majority of TSMC's initial 2nm chips capacity to rolling out an "Alternative App Store" model in the EU, Apple's moves were far-reaching. 
Via Benzinga
Tim Cook Says 'Thanks' After Banned Apple Watch Feature Saves Teen From Altitude Sickness
A teenager suffering from altitude sickness in Peru was saved using the blood oxygen detection feature on an Apple Watch, a function currently banned in the U.S. due to a patent dispute with Masimo... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Samsung To Reportedly Level Up Its Health Tech Game — Plans To Challenge Apple With Noninvasive Blood Sugar Monitoring
Samsung Electronics is stepping up its health tech game by developing noninvasive glucose and continuous blood pressure monitoring technology, challenging Apple and other tech giants in the health-care... 
Via Benzinga
Apple's Move To Remove Blood Oxygen Feature In US Watches May Affect Sleep Apnea Detection, Says Mark Gurman
Apple's removal of the blood oxygen tracking feature from its smartwatches could impact its future health-related capabilities, including sleep apnea detection, as highlighted by Mark Gurman. 
Via Benzinga
Apple Watch Sidesteps Looming Ban, Cupertino Giant Outshines Samsung In Sales, Tim Cook Shows BTS Of Vision Pro: This Week In Appleverse
From securing the pole position in global smartphone shipments to navigating tricky patent disputes, Apple was in the thick of news this week 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Masimo CEO 'Wholeheartedly' Feels Apple Watch Users Are Better Off Without Blood Oxygen Monitoring Feature
"Pulse oximetry is not useful unless it is a continuous monitor. That happens during sleep," Kiani explained. 
Via Benzinga
Apple Watch Versions Minus Blood Oxygen Feature To Go On Sale In US As Cupertino Devises Way To Sidestep Looming Ban
Apple Inc. modifies its latest Apple Watch models for the U.S. market by removing the blood oxygen feature, in response to a pending ban due to an intellectual property dispute with Masimo... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Masimo Announces Reinstatement of Import Ban on Infringing Apple Watches
From Masimo
Via Business Wire
Bob Chapek Goes From Disney To Battling Apple: Inside New Role Announced For Former Media Executive
Bob Chapek is moving from Disney to healthcare company Masimo. Chapek's new company is working through patent litigation against Apple. 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Courts Reinstate Ban On Apple Watches With Blood Oxygen Sensors
A federal appeals court on Wednesday shut down Apple's attempt to allow U.S. imports of Apple Watches with blood-oxygen sensors while it appeals a ban on the products. 
Via Benzinga
Masimo Announces New Member of the Board of Directors
From Masimo
Via Business Wire
Apple Dodges Import Ban In Apple Watch Patent Battle With Masimo
Apple potentially avoids import ban for Apple Watch models in patent dispute with Masimo, with software redesign to remove blood-oxygen feature. 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
ITC Wants Apple Ban Reinstated, Calls Apple's Arguments 'Weak And Unconvincing'
The U.S. International Trade Commission (ITC) has opposed Apple's plea to put on hold an import ban on certain Apple Watch models. 
Via Benzinga
Masimo Announces Select Preliminary 2023 Financial Results and 2024 Guidance
From Masimo Corporation
Via Business Wire
Apple Stock Is Still A Buy. Here’s Why.
Investors should remain bullish on AAPL stock as the company grows its services business and brings new products to market. 
Via InvestorPlace
There's Uncertainty Around Apple's Patent Appeal For Watch, Masimo's Royalty Exposure Is Priced In - Analyst Downgrades
Needham downgraded Masimo Corporation (NASDAQ: MASI), noting that though Apple Inc (NASDAQ: AAPL) royalties are not certain, but are mostly priced into MASI shares. 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Is the Apple Watch ban the tipping point?
Apple Inc. (NYSE: AAPL) had a stellar 2023, gaining 49.39% for 2023 while maintaining the largest weighting in the S&P 500. While the 
Via MarketBeat
Topics Intellectual Property Stocks
Exposures Intellectual Property US Equities
Bear Of The Day: Masimo
Masimo (MASI) , a medical device company, has seen significant downward pressure on its earnings estimates over the last two months, downgrading the stock to a Zacks Rank #5 (Strong Sell), and... 
Via Talk Markets
Benzinga Bulls And Bears: Tesla, Apple, Microsoft, Plug Power And Analyst Sees Precursor To Dogecoin Rally
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
Apple Is 'Working Desperately' To Overcome Watch Import Ban With Software Redesign, Aiming For January Launch Amid Patent-Infringement Case: Report
Apple is redesigning software for compliance, hoping to gain approval from a U.S. customs agency by Jan.12 to sell compliant device versions. 
Via Benzinga
Joe Biden Vs. Apple Watch: White House Upholds Ban, Masimo CEO One Of President's 'Closest Friends'
The Apple Watch vs. Masimo battle could spill over into politics with the CEO of Masimo a major Democratic donor and friend of Joe Biden. 
Via Benzinga
S&P 500 Inches Higher, Small-Cap Rally Stalls, Bitcoin Sinks: What's Driving Markets Thursday?
Wall Street is navigating another quiet session characterized by low trading volumes in the post-holiday period. The S&P 500 index continues its gradual ascent toward retesting its all-time highs,... 
Via Benzinga
Topics Stocks
Exposures US Equities
Apple’s Market Maneuvers: Is AAPL Stock a Smart Buy at $193?
A ban on the Apple Watch could hit AAPL stock hard as the wearable is the tech stock's second biggest money-maker 
Via InvestorPlace
How A Late-Night Email To Tim Cook 10 Years Ago Possibly Triggered Masimo's Battle To Get Apple Watch Banned
In 2013, a scientist named Marcelo Lamego fired off an email to Cook, pitching a vision that could propel Apple to the forefront of the medical, fitness, and wellness market, Bloomberg reported. 
Via Benzinga
US Stocks Pause, Gold Rises As Dollar, Treasury Yields Fall: What's Driving Markets Wednesday?
The U.S. stock market experienced a quiet day on Wednesday, with major indices showing minimal movement amid typical year-end low volume activity. The S&P 500 hovered around 4,777 points, remaining... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.